Search

Your search keyword '"Vaeth, Elisabeth"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Vaeth, Elisabeth" Remove constraint Author: "Vaeth, Elisabeth" Database Unpaywall Remove constraint Database: Unpaywall
35 results on '"Vaeth, Elisabeth"'

Search Results

1. Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020

2. 1932. Molecular Epidemiology of NDM-producing Acinetobacter baumannii in the US—October 2013—March 2022

4. 1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020

5. 2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022

6. 970. Assessing the burden of Acinetobacter baumannii and Candida auris among ventilated patients in Maryland: A statewide period prevalence survey of two urgent threats

7. Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation

8. Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020

9. Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors —Emerging infections program, United States, 2012-2015

10. 86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020

11. Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC’s Emerging Infections Program, United States, 2016–2018

12. Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

13. Carbapenem-Resistant Acinetobacter baumannii Incidence Trends Identified Through the Emerging Infections Program, 2012–2018

14. Identification of Colonized Patients During an Outbreak of Candida auris Using a Regional Health Information Exchange

15. Characteristics Associated with Death in Patients with Carbapenem-Resistant Acinetobacter baumannii, United States, 2012–2017

16. Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected Through the Emerging Infections Program

17. Evaluation of Discrepancies in Carbapenem Minimum Inhibitory Concentrations Obtained at Clinical Laboratories Compared to a Public Health Laboratory

18. Characterization of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant Enterobacteriaceae, United States, 2015–2017

19. 2449. Early Detection of Candida auris is Essential to Control Spread: Four Effective Active Surveillance Strategies

20. 507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017

21. 486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018

24. 1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017

25. 1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016

26. Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015

28. Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015

30. Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) in 6 US communities

31. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013

32. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-ResistantEnterobacteriaceae

33. 1800Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae

Catalog

Books, media, physical & digital resources